Parallel Sessions – 專題報告 (December 2-3, 2017)

Prof. Zhixiu LIN (林志秀教授)
The Chinese University of Hong Kong
Dr. Hans LAMPE
Rostock University Medical Centre, Germany
Prof. Kelvin Kam Chuen CHAN (陳金泉教授)
Western Sydney University, Australia
     
     
Prof. Lee-Yan SHEEN (沈立言教授)
National Taiwan University, Taiwan
Prof. Zhen CHEN (陳震教授)
Fudan University Shanghai Cancer Centre, PRC
Prof. Zhiling YU (禹志領教授)
Hong Kong Baptist University, HKSAR
     
     
Dr. George Pak Hang LEUNG (梁柏行博士)
The University of Hong Kong, HKSAR
Prof. Zhaoxiang BIAN (卞兆祥教授)
Hong Kong Baptist University, HKSAR
Prof. Yizhun ZHU (朱依諄教授)
Macau University of Science and Technology,
Macau SAR
     
     
Prof. Xuanbin WANG (汪選斌教授)
Hubei University of Medicine, PRC
Dr. Hisayoshi NORIMOTO (範本文哲博士)
PuraPharm Corportation Ltd, Japan
Prof. Weidong PAN (潘衛東教授)
The Key Laboratory of Chemistry for
Natural Products of Guizhou Province
and Chinese Academy of Sciences, PRC
     
     
Dr. Jianhui RONG (榮建輝博士)
The University of Hong Kong, HKSAR
Dr. Liu YANG(楊柳博士)
Tasly Holding GroupCo. Ltd. PRC
(in representation of Dr He SUN)
Dr. Albert B WONG (黃伯偉博士)
Zigen Medical Sciences Limited, HKSAR
     
     
Dr Xiaoying SUN (孫曉穎博士)
Qingdao University School of Pharmacy, PRC
Dr Chuanbin YANG (楊傳彬博士)
Hong Kong Baptist University, HKSAR
Mr Xiaoxin CHEN (陳小鑫先生)
The University of Hong Kong, HKSAR
     
     
Dr Jiawei LI (李佳蔚博士)
Fudan University Zhongshan Hospital, PRC
Dr Yongxian LI (李永賢博士)
Guangzhou University of Chinese Medicine, PRC
Ms Sha LI (李莎女士)
The University of Hong Kong, HKSAR
     
     
Mr Weifeng WU (吳偉鋒先生)
The University of Hong Kong, HKSAR
Mr Jingjing LI (李晶晶先生)
The University of Hong Kong, HKSAR
Ms Chien Shan CHENG (程健珊女士)
Fudan University Shanghai Cancer Center, PRC
     
     


Return to Index




Copyright © 2017. School of Chinese Medicine, The University of Hong Kong.
All rights reserved.